Table 1.
Characteristic | Mean (SD) or N(%) or median (25%, 75%) |
---|---|
Clinical characteristics | |
Age, yr | 63.9 (11.9) |
Male | 876 (64.1%) |
Race | |
American Indian/Alaskan Native | 14 (1.0%) |
Asian | 4 (0.3%) |
Black | 22 (1.6%) |
Native Hawaiian/Pacific Islander | 1 (0.1%) |
White | 1269 (92.8%) |
Unknown/Other | 57 (4.2%) |
BMI, kg/m2 | 30.8 (6.7) |
Hypertension | 921 (67.4%) |
Diabetes mellitus | 186 (13.6%) |
Kidney function | |
Prenephrectomy eGFR, ml/min per 1.73 m2 | 72.1 (18.8) |
Postnephrectomy eGFR, ml/min per 1.73 m2 | 51.2 (13.7) |
24-h urine protein, mga | 154 (87, 307) |
Baseline biopsy measures | |
Superficial glomerular volume, mm3 | 0.0025 (0.0011) |
Middle glomerular volume, mm3 | 0.0032 (0.0012) |
Deep glomerular volume, mm3 | 0.0029 (0.0011) |
Superficial proximal tubular diameter, μm | 54.2 (6.4) |
Middle proximal tubular diameter, μm | 58.1 (6.6) |
Deep proximal tubular diameter, μm | 56.6 (6.5) |
Superficial distal tubular diameter, μm | 43.1 (4.4) |
Middle distal tubular diameter, μm | 46.9 (4.7) |
Deep distal tubular diameter, μm | 47.2 (5.0) |
% Luminal stenosis | 54.5 (15.5) |
% Fibrosis | 3.6 (7.5) |
IFTA foci density, per cm2 | 25.1 (20.8) |
Macroscopic measuresb | |
Cortex volume, cm3 | 125.0 (36.9) |
Medulla volume, cm3 | 48.6 (15.4) |
Tumor volumec, cm3 | 155 (61, 406) |
Outcomes during follow-up | |
Progressive CKD, % | 62 (4.5%) |
BMI, body mass index; IFTA, interstitial fibrosis and tubular atrophy.
Urine protein data missing in 183 patients.
Cortex and medulla volume could not be obtained in 704 patients because of poor cm differentiation on the images or lack of digital images.
Tumor volume missing in 172 patients because of lack of digital images.